BioCentury
ARTICLE | Clinical News

IGT preclinical data

April 15, 2013 7:00 AM UTC

IGT reported results of studies in a mouse model of cervical cancer that compared AVLB with a similar drug, Navelbine, produced by Glaxo Wellcome. Separate groups of mice were given 20 mg/kg doses of...